Horizon Therapeutics Announced Acquisition By Amgen Approved By The High Court Of Ireland
Portfolio Pulse from Charles Gross
Horizon Therapeutics' acquisition by Amgen has been approved by the High Court of Ireland. The acquisition was initially agreed upon on December 11, 2022, and is expected to be finalized on October 6, 2023, pending the delivery of the court order to the Registrar of Companies in Ireland.
October 05, 2023 | 11:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen's acquisition of Horizon Therapeutics has been approved, which could potentially strengthen its portfolio and market position.
Acquisitions often lead to an increase in the acquiring company's stock price due to potential synergies, increased market share, and improved financial performance. Therefore, this news is likely to have a positive impact on Amgen's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Horizon Therapeutics' acquisition by Amgen has been approved, which could lead to a rise in its stock price.
The approval of the acquisition often leads to a rise in the stock price of the company being acquired due to the premium typically paid in such transactions. Therefore, this news is likely to have a positive impact on Horizon Therapeutics' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100